Drug Type Small molecule drug |
Synonyms WXSH0024 |
Target |
Action antagonists |
Mechanism AT2R antagonists(Angiotensin II receptor type 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuralgia | Phase 1 | China | 06 Jul 2022 |





